Recombinant human PADI1 + PADI2 +PADI3 + PADI4 + PADI6 protein (ab170409)
Key features and details
- Expression system: Baculovirus infected Sf9 cells
- Purity: > 95% Densitometry
- Active: Yes
- Tags: proprietary tag N-Terminus
- Suitable for: Functional Studies, SDS-PAGE
-
Product name
Recombinant human PADI1 + PADI2 +PADI3 + PADI4 + PADI6 protein -
Biological activity
Sample Mass Spectrometry DataPeptide Sequence PAD treated Negative control
XXRXXXXXXXXX 5 reads, 3 citrullination No citrullination
XXXXXXXXXXRXXXRXXXX 8 reads, 4 citrullination No citrullination
XXXXXXRXXXXXXXX 16 reads, 6 citrullination No citrullination -
Purity
> 95 % Densitometry. -
Expression system
Baculovirus infected Sf9 cells -
Protein length
Full length protein -
Animal free
No -
Nature
Recombinant -
-
Species
Human -
Tags
proprietary tag N-Terminus
-
Preparation and Storage
-
Stability and Storage
Shipped on dry ice. Upon delivery aliquot and store at -80ºC. Avoid freeze / thaw cycles.
pH: 7.50
Constituents: 0.31% Glutathione, 0.002% PMSF, 0.004% DTT, 0.79% Tris HCl, 0.003% EDTA, 25% Glycerol (glycerin, glycerine), 0.88% Sodium chlorideThis product is an active protein and may elicit a biological response in vivo, handle with caution.
Images
-
SDS PAGE analysis of ab170409
-
SDS-PAGE analysis of ab170409.
Lane 1: PADI1
Lane 2: PADI4
Lane 3: PADI3
Lane 4: PADI6
Lane 5: PADI2
Lane 6: ab170409PADI1: approx. 95 kDa
PADI4: approx. 96 kDa
PADI3: approx. 97 kDa
PADI6: approx. 100 kDa
PADI2: approx. 99 kDa -
Activity data using ab170409.